ADMA Biologics
ADMA
#3618
Rank
โ‚น343.45 B
Marketcap
โ‚น1,439
Share price
-3.34%
Change (1 day)
-2.31%
Change (1 year)

Market capitalization of ADMA Biologics (ADMA)

Market cap: โ‚น343.45 Billion

As of February 2026 ADMA Biologics has a market cap of โ‚น343.45 Billion. This makes ADMA Biologics the world's 3618th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ADMA Biologics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น343.45 B-16.84%
2025โ‚น413.01 B16.71%
2024โ‚น353.87 B316.18%
2023โ‚น85.02 B19.88%
2022โ‚น70.92 B245.13%
2021โ‚น20.55 B52.41%
2020โ‚น13.48 B-20.31%
2019โ‚น16.92 B118.44%
2018โ‚น7.74 B-16.6%
2017โ‚น9.28 B107.16%
2016โ‚น4.48 B-21.96%
2015โ‚น5.74 B-12.66%
2014โ‚น6.57 B46.91%
2013โ‚น4.47 B

End of Day market cap according to different sources

On Feb 5th, 2026 the market cap of ADMA Biologics was reported to be:

โ‚น342.54 Billion
by Nasdaq info icon info icon
โ‚น343.45 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Repligen
RGEN
โ‚น709.85 B 106.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น115.47 B-66.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
โ‚น3.72 B-98.92%๐Ÿ‡บ๐Ÿ‡ธ USA